News

08.12.2014

Abstract submission is now open

The CIMT program committee is calling for abstract submissions in the categories Therapeutic Vaccination, New Targets & New Leads, Tumor Biology & Interaction with the Immune System, Immunomonitoring, Cellular Therapy, Improving Immunity.

more

The CIMT program committee is calling for abstract submissions in the categories Therapeutic Vaccination, New Targets & New Leads, Tumor Biology & Interaction with the Immune System, Immunomonitoring, Cellular Therapy, Improving Immunity.

All accepted abstracts will be presented as posters. Selected abstracts will be presented as short talks. The abstract submission deadline will be February 27, 2015.

Go to http://www.abstractserver.com/cimt2015/absmgm/ to submit your abstract.

18.11.2014

Call for Abstracts

Submit your abstract and participate in Europe's largest expert meeting on cancer immunotherapy research and development. Abstract submission will open December 8.

more

CIMT 2015 - Call for Abstracts

13th Annual Meeting of the Association for Cancer Immunotherapy
"The right patient for the right therapy"
May 11-13 2014 in Mainz, Germany

Submit your abstract and participate in Europe's largest expert meeting on cancer immunotherapy research and development. Abstract submission will open December 8.
The abstract committee is calling for abstract submissions in the sub-specialties of:
Therapeutic Vaccination, Immunomonitoring, Cellular Therapy, New Targets & New Leads, Tumor Biology and Interaction with the Immune System, Improving Immunity, Cellular Therapy, New Targets & New Leads
All accepted abstracts will be presented as posters. Selected abstracts will be presented as short talks. 

11.11.2014

2015 Keynote Lecture

Alexander Eggermont, Director General of France's Institut Gustave Roussy, will give the keynote lecture of the 2015 CIMT Annual Meeting.  

more

Eggermont is Professor of Surgical Oncology and Professor of International Networking in Cancer Research at the Erasmus University Medical Centre in Rotterdam. He holds the ‘Joseph Maisin Chair in Oncology at the Catholic University of Leuven in Belgium. In 1987 he obtained his PhD on ‘Interferon and IFN-Inducers in the Treatment of Cancer’ at the Erasmus University Rotterdam and is a former Fellow of the NCI Surgery Branch, NIH, Bethesda, USA.

His clinical specialties include melanoma, sarcoma and regional therapy techniques as well as general drug development and clinical trial methodology. He is a past Chair of the EORTC MG Group and current Chair of the Adjuvant Therapy Committee EORTC Melanoma Group. His basic research field is in tumor immunology, advanced imaging models and tumor pathophysiology.

Professor Eggermont is the author or co-author of over 600 peer-reviewed publications, book chapters and monographs. More than 30 PhD theses have originated in his clinical and basic laboratory research programs at the Erasmus University MC Rotterdam.

 

31.10.2014

F1000 Posters

View some fantastic posters from the 2014 CIMT Annual Meeting on F1000 Posters. More than 321 abstracts were presented at CIMT 2014.

more

View some fantastic posters from the 2014 CIMT Annual Meeting on F1000 Posters. More than 321 abstracts were presented at CIMT 2014.

F1000Posters is an open access repository that provides a permanent, structured environment for the deposition of posters and slide presentations as well as a trustworthy venue for ongoing discussion and development of the information being presented.
The early scientific information presented in conference presentations is universally agreed to be an important resource but, unfortunately, it is almost always completely lost once a conference is over. As a result, the work is only viewed by a handful of people before it disappears, either forever or until the research is later published as a paper. F1000Posters enables researchers to maximize the value of their presented work by dramatically increasing access and by helping to prevent lengthy delays before others can benefit from new research. The feedback gained by scientists from such early dissemination may help direct future work and also may reduce the duplication of effort between labs and departments, whether by speeding progress towards a similar goal or by preventing the replication of work that has previously failed.

F1000 Posters

CIMT

The Association for Cancer Immunotherapy

Welcome to Europe’s largest meeting focused on cancer immunotherapy research and development.

CIMT is a members-based information and education platform that facilitates the knowledge exchange between academic and industry scientists, physicians and regulatory authorities who research and develop cancer immunotherapies. CIMT was founded in 2002 by physicians and researchers from different fields of clinical and theoretical medicine as an independent non-profit organization. CIMT has its offices in Mainz, Germany, and is financed by donations, congress fees, industry sponsorship and by public and foundation grants.

Visit the CIMT website | www.cimt.eu